NSE - Delayed Quote INR

Medicamen Biotech Limited (MEDICAMEQ.NS)

Compare
485.70 -27.60 (-5.38%)
At close: 3:29 PM GMT+5:30
Currency in INR All numbers in thousands
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Total Revenue
1,804,117.00
1,793,062.00
1,408,674.00
1,154,453.00
1,127,160.83
--
Cost of Revenue
958,224.00
925,977.00
720,934.00
674,574.00
791,999.06
--
Gross Profit
845,893.00
867,085.00
687,740.00
479,879.00
335,161.77
--
Operating Expense
730,271.00
715,614.00
512,686.00
289,885.00
163,632.69
--
Operating Income
115,622.00
151,471.00
175,054.00
189,994.00
171,529.08
--
Net Non Operating Interest Income Expense
-41,464.00
-43,972.00
-29,227.00
-18,057.00
-13,582.13
--
Pretax Income
99,486.00
130,756.00
170,450.00
180,948.00
163,940.12
--
Tax Provision
36,029.00
35,816.00
23,165.00
31,971.00
42,645.72
--
Net Income Common Stockholders
81,050.00
109,310.00
148,441.00
148,977.00
121,294.40
--
Diluted NI Available to Com Stockholders
81,050.00
109,310.00
148,441.00
148,977.00
121,294.40
--
Basic EPS
5.26
7.50
11.82
12.19
9.93
--
Diluted EPS
5.26
7.50
11.82
12.19
9.93
--
Basic Average Shares
12,714.60
14,574.67
12,558.46
12,216.60
12,216.60
--
Diluted Average Shares
12,714.60
14,574.67
12,558.46
12,216.60
12,216.60
--
Rent Expense Supplemental
--
--
3,976.00
2,527.00
2,161.75
2,391.09
Total Expenses
1,688,495.00
1,641,591.00
1,233,620.00
964,459.00
955,631.75
--
Net Income from Continuing & Discontinued Operation
81,050.00
109,310.00
148,441.00
148,977.00
121,294.40
--
Normalized Income
81,050.00
109,310.00
148,441.00
154,538.49
121,243.36
--
Interest Income
--
--
7,207.00
1,354.00
1,533.09
3,195.84
Interest Expense
41,464.00
43,972.00
29,227.00
14,006.00
10,640.11
--
Net Interest Income
-41,464.00
-43,972.00
-29,227.00
-18,057.00
-13,582.13
--
EBIT
140,950.00
174,728.00
199,677.00
194,954.00
174,580.23
--
EBITDA
212,677.00
245,660.00
263,343.00
252,668.00
199,777.36
--
Reconciled Cost of Revenue
958,224.00
925,977.00
720,934.00
674,574.00
791,999.06
--
Reconciled Depreciation
71,727.00
70,932.00
63,666.00
57,714.00
25,197.13
--
Net Income from Continuing Operation Net Minority Interest
81,050.00
109,310.00
148,441.00
148,977.00
121,294.40
--
Total Unusual Items Excluding Goodwill
--
--
--
-6,755.00
68.98
--
Total Unusual Items
--
--
--
-6,755.00
68.98
--
Normalized EBITDA
212,677.00
245,660.00
263,343.00
259,423.00
199,708.38
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
--
--
--
-1,193.51
17.94
--
3/31/2020 - 10/27/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers